The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug P...
The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Glioblastoma (GBM) is the most common malignant brain tumour among adult patients and represents an almost universally fatal disease. Novel therapies for GBM are being developed under the orphan drug legislation and the knowledge on the molecular makeup of this disease has been increasing rapidly. However, the clinical outcomes in GBM patients with...
Alternative Titles
Full title
The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2549209707
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2549209707
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0252924
